Investor

As a serial entrepreneur, Avi Lasarow has set up three successful companies in the last twenty years and is now an angel investor looking to support the next generation of healthtech start-ups.

Having completed four years from selling DNAfit to Prenetics for $10 million through to exiting in 2022, Avi is looking forward to helping more ambitious founders build disruptive technologies to help push healthcare forward and solve healthcare problems.

His insights for investment are summed up in three questions. First - does the company’s product meet a need that Avi has personally experienced?

Second, is there a founder-product-market fit, meaning does the startup have experience in its market? And third, who are the other investors and do they have a good track record in their own business or in other investments?

In 2023, Avi Lasarow invested in Floe Oral Care, further demonstrating his commitment to innovative health and wellness solutions. Building on this momentum, in 2024, he made additional strategic investments in Sanius Health, Healthtech1, and a patent portfolio that has recently settled with major US-based technology players for breach of patent. This includes successful settlements with Samsung and Withings, with ongoing cases against Google and other prominent companies.

Avi’s investment approach focuses on identifying disruptive technologies with the potential for significant global impact, aligning with his vision of fostering groundbreaking solutions that address critical challenges in healthcare and beyond.